The development of the biotechnology company “Memel Biotech” will be led by K. Karl | Business

K.Karl will be responsible for the development of Memel Biotech’s partner network, cooperation with innovative companies around the world developing medical preparations in the field of cell and gene therapy – from clinical trials to production and commercialization stages.

“We want to bring together professionals in our field, with whom we could achieve an even greater breakthrough in the country’s biotechnologies and provide patients in Lithuania and other countries with new opportunities to receive the most innovative and advanced treatment methods. Karolina’s accumulated experience in the field of investments and life sciences will allow for a more focused search for partners and new opportunities for cooperation all over the world”, says Agnė Vaitkevičienė, head of the Memel Biotech company.

Karolina Karl has worked at the foreign investment agency Invest in Lithuania for the past seven years. Having started as a junior investment advisor, she led the Life Sciences team for the past few years – contributed to the development of investors in the country, the representation of the biotechnology sector in the international arena, and the development of Lithuania’s life sciences strategy.

“For the past seven years, having cooperated with representatives of the biotechnology sector all over the world, I see the company Memel Biotech as a very promising and strong player in this industry – both here in Lithuania, gathering talents, and in international markets. Therefore, I am very happy that I will have the opportunity to contribute even more actively to the growth of the company and the entire sector in Lithuania and its representation in the international space”, says K.Karl, the business development manager of the biotechnology company.